PRASAD SUYASH Insider Trading
Get the latest insider transactions of PRASAD SUYASH. PRASAD SUYASH is Senior VP & Chief Med Officer in Audentes Therapeutics, Inc. ($BOLD) and CMO and Head of R&D in Taysha Gene Therapies, Inc. ($TSHA). Discover the current value of PRASAD SUYASH shares.
Address: C/O AUDENTES THERAPEUTICS, INC. 600 CALIFORNIA STREET, 17TH FLOOR SAN FRANCISCO 94108CA
PRASAD SUYASH is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| BOLD | Audentes Therapeutics, Inc. | Senior VP & Chief Med Officer | 17,479 | 276,692.57 |
| TSHA | Taysha Gene Therapies, Inc. | CMO and Head of R&D | 672,589 |
Insider Trading Transactions of PRASAD SUYASH
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jan 20 2021 | TSHA | Taysha Gene Therapies, In ... | PRASAD SUYASH | CMO and Head of R&D | Option Exercise | 31.00 | 80,000 | 2,480,000 | 80,000 |
| Sep 30 2020 | TSHA | Taysha Gene Therapies, In ... | PRASAD SUYASH | CMO and Head of R&D | Buy | 0.00 | 3,844 | 0 | 672,589 |
| Sep 30 2020 | TSHA | Taysha Gene Therapies, In ... | PRASAD SUYASH | CMO and Head of R&D | Option Exercise | 0.00 | 3,529 | 0 | 0 |
| Sep 30 2020 | TSHA | Taysha Gene Therapies, In ... | PRASAD SUYASH | CMO and Head of R&D | Buy | 0.00 | 3,844 | 0 | 672,589 |
| Sep 30 2020 | TSHA | Taysha Gene Therapies, In ... | PRASAD SUYASH | CMO and Head of R&D | Option Exercise | 0.00 | 3,529 | 0 | 0 |
| Sep 25 2020 | TSHA | Taysha Gene Therapies, In ... | PRASAD SUYASH | CMO and Head of R&D | Buy | 0.00 | 668,745 | 0 | 668,745 |
| Jun 07 2019 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 37.31 | 757 | 28,244 | 17,479 |
| Jun 07 2019 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 37.31 | 757 | 28,244 | 17,479 |
| May 15 2019 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 10,000 | 7,900 | 28,236 |
| May 15 2019 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 36.98 | 9,946 | 367,761 | 18,290 |
| May 15 2019 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 37.72 | 54 | 2,037 | 18,236 |
| May 15 2019 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 0.79 | 10,000 | 7,900 | 30,870 |
| Feb 27 2019 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 10,000 | 7,900 | 28,236 |
| Feb 27 2019 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 30.06 | 10,000 | 300,553 | 18,236 |
| Feb 27 2019 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 0.79 | 10,000 | 7,900 | 40,870 |
| Feb 08 2019 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.00 | 17,500 | 0 | 18,236 |
| Feb 08 2019 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 24.74 | 48,750 | 1,206,075 | 48,750 |
| Nov 16 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 19.64 | 736 | 14,451 | 736 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 100 | 79 | 100 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 39.52 | 100 | 3,952 | 0 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 1,101 | 870 | 1,101 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 38.85 | 1,101 | 42,777 | 0 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 3,900 | 3,081 | 3,900 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 37.82 | 3,900 | 147,512 | 0 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 200 | 158 | 200 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 36.32 | 200 | 7,263 | 0 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 4,699 | 3,712 | 4,699 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 35.60 | 4,699 | 167,283 | 0 |
| Oct 02 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 0.79 | 10,000 | 7,900 | 50,870 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 4,989 | 3,941 | 4,989 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 38.02 | 4,989 | 189,704 | 0 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 5,011 | 3,959 | 5,011 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 38.79 | 5,011 | 194,364 | 0 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 0.79 | 4,989 | 3,941 | 65,881 |
| Jul 05 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 0.79 | 5,011 | 3,959 | 60,870 |
| Mar 29 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 7,800 | 6,162 | 7,800 |
| Mar 29 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 30.03 | 7,800 | 234,195 | 0 |
| Mar 29 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 0.79 | 7,800 | 6,162 | 70,870 |
| Mar 28 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 1,900 | 1,501 | 1,900 |
| Mar 28 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 30.00 | 1,900 | 57,000 | 0 |
| Mar 28 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 300 | 237 | 300 |
| Mar 28 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 30.00 | 300 | 9,000 | 0 |
| Mar 28 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 0.79 | 1,900 | 1,501 | 78,970 |
| Mar 28 2018 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 0.79 | 300 | 237 | 78,670 |
| Dec 05 2017 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 6,770 | 5,348 | 6,770 |
| Dec 05 2017 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 28.45 | 6,770 | 192,613 | 0 |
| Dec 05 2017 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 1,230 | 972 | 1,230 |
| Dec 05 2017 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 28.98 | 1,230 | 35,651 | 0 |
| Dec 05 2017 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 0.79 | 8,000 | 6,320 | 80,870 |
| Nov 17 2017 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 27.39 | 75,000 | 2,054,250 | 75,000 |
| Sep 01 2017 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Buy | 0.79 | 8,000 | 6,320 | 8,000 |
| Sep 01 2017 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Sell | 21.44 | 8,000 | 171,481 | 0 |
| Sep 01 2017 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 0.79 | 8,000 | 6,320 | 88,870 |
| Jan 27 2017 | BOLD | Audentes Therapeutics, In ... | PRASAD SUYASH | Senior VP & Chief Med ... | Option Exercise | 15.26 | 70,000 | 1,068,200 | 70,000 |